Received Mar 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | JE9GP | — |
had accidentally been exposed to 13.9 degree Fahrenheit/ accidentally administered to six pediatric patients; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in specified number of pediatric patients who received MMR (Priorix) (batch number JE9GP, expiry date 01-SEP-2025) for prophylaxis. On an unknown date, the specified number of pediatric patients received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced incorrect storage of drug (Verbatim: had accidentally been exposed to 13.9 degree Fahrenheit/ accidentally administered to six pediatric patients). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 06-MAR-2025 A nurse practitioner contacted the GSK to report that Priorix vaccine had accidentally been exposed to 13.9 degree Fahrenheit for what would seem a period of one month but the health care professional was uncertain if this was true and accidentally administered to six pediatric patients which led to incorrect storage of drug. The health care professional did not their age gender or initials. Follow up was consented to for this case and they requested thermostability data and clinical recommendations, receiving the standard response letter and the contact information for the CDC immunization hotline.